Escherichia coli strain Nissle 1917 (Mutaflor Suspension®,) Suspension, finished product (probiotic) for pediatric use

Product description

General use:
  • Diarrhea in newborns, infants and children
  • Diarrhea in newborns, infants and children under tube feeding
  • Colonisation prophylaxis in premature and full-term neonates
  • Enhacement of postnatal immune competence in premature and full-term neonates
CTD is available.

Live Biotherapeutic Product (LBP)
Read more

Specifications

Categories Generic APIsGeneric Probiotics; APIsProbiotics
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Supplied from Germany
Selling Points Brand Name; Children's Health F&B; Digestive Health; Immune Health; International Approvals/Standards; Place of Origin; Quality Service; Reputation; Small Orders Accepted
Show more specifications

More products from Pharma Zentrale GmbH

View all our products (27)

Products from other suppliers

Escherichia coli strain Nissle 1917 (Mutaflor Suspension®,) Suspension, finished product (probiotic) for pediatric use

Contact information

Address

Telephone

Website

View all contact information